Renal Failure, Chronic Clinical Trial
Official title:
Elimination of Protein-bound Uremic Retention Solutes by Prometheus Artificial Hepatic System Versus Conventional Dialysis
Comparison of the efficacy of dialysis by conventional dialysis versus Prometheus artificial hepatic system
After inclusion, patients will be dialysed with low-flux artificial kidneys. 1 week of dialysis exists of 3 days of dialysis. In week 4, day 2, patients will be treated once with the Prometheus artificial hepatic system or with high-flux dialysis. The other days low-flux kidneys will be used. Week 5 and 6 are a wash-out period. Week 7 is identical to week 4 but the other system than in week 4 is used. Blood samples are taken at regular moments in week 3, week 4 (day 2) and week 7 (day 2). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00259025 -
Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients
|
Phase 2 | |
| Completed |
NCT00176059 -
Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
|
Phase 0 | |
| Completed |
NCT00439023 -
Glucose in Dialysis Water in Non-diabetics
|
Phase 4 | |
| Completed |
NCT00438503 -
Glucose in Dialysis Water in Diabetics With Chronic Renal Failure
|
Phase 4 | |
| Completed |
NCT03904836 -
Tobramycin Administered at the Beginning of Dialysis
|
Phase 1 | |
| Not yet recruiting |
NCT02259296 -
Timing for Arteriovenous Fistula Creation and Its Effect on Target Organs in Patients With Chronic Renal Failure
|
N/A | |
| Completed |
NCT00150891 -
Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
|
N/A | |
| Completed |
NCT01875523 -
PK of Serelaxin in Severe Renal Impairment and ESRD
|
Phase 1 | |
| Completed |
NCT00438295 -
Temperature Control During Dialysis Treatment
|
Phase 4 | |
| Terminated |
NCT00664066 -
DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)
|